Insights On Outsourced Drug Development

  1. Monolithic Columns As Downstream Processing Solutions For Lentiviral Purification 11/27/2024

    Third-generation lentiviral vectors enable efficient gene delivery, but purification challenges limit in vivo applications. Monolithic columns and advanced assays show promise for downstream processes.

  2. Comprehensive GMP Testing Services 3/31/2025

    Eurofins delivers global GMP testing with 45+ facilities, ensuring regulatory acceptance, quality, and trusted service from starting materials to finished products.

  3. Welcoming The "Era Of ADCs" 12/5/2023

    Dr. Loretta Itri sat down to explore the promise of TRODELVY®️ and other antibody-drug conjugates as transformative treatments for a range of malignancies and intractable diseases.

  4. The Role Of CDMOs In Supporting Generic Drug Development 7/15/2025

    Bringing complex generics to market requires deep expertise. Learn how a CDMO can help navigate regulatory, technical, and commercial challenges with end-to-end development and manufacturing support.

  5. Reduce Costly Scale-Up Problems 4/11/2024

    Scaling a new drug formulation from development to manufacturing often presents challenges, but there are ways to minimize deviations and streamline your transition.

  6. In Vitro/In Vivo Permeability: A 4-Cell Line Study 5/21/2025

    Evaluate drug absorption potential across diverse cell barriers and transporter systems using our comparative permeability studies with a variety of cell lines and standard compounds.

  7. AI-Powered Digital Pathology For Pulmonary Fibrosis Biomarker Quantification 3/27/2025

    Uncover how AI-driven digital pathology is revolutionizing the detection and quantification of pulmonary fibrosis markers in whole lung sections, offering new opportunities for clinical research.

  8. Leveraging Surface Plasmon Resonance For Characterizing Ternary Complexes 6/13/2025

    Uncover how Surface Plasmon Resonance (SPR) can be used to gain real-time, label-free insights into PROTAC binding kinetics and ternary complex formation.

  9. A Holistic Approach To Understanding High And Low HEK293 Producer 4/4/2025

    Despite advancements in AAV-based gene therapy, key aspects of AAV biology and production remain unclear. Find out how researchers are exploring HEK293 subclones to identify traits that enhance viral vector yields.

  10. The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly 3/3/2025

    In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.